Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Is Kidney Stone Associated with Thyroid Disease? The United States National Health and Nutrition Examination Survey 2007-2018

Author(s): Wenya Xue, Zihan Xue, Yanbing Liu, Pan Yin, Luyu Liu, Shen’ao Qu, Shaobo Wu* and Chuance Yang*

Volume 24, Issue 11, 2024

Published on: 08 January, 2024

Page: [1323 - 1334] Pages: 12

DOI: 10.2174/0118715303268738231129093935

Price: $65

Abstract

Background: Kidney stones and thyroid disease are two common diseases in the general population, with multiple common risk factors. The associations between kidney stones and thyroid disease are unclear.

Aim: This study aims to assess the association between ‘once had a thyroid disease’ and the odds of kidney stones.

Methods: Adult participants from the National Health and Nutrition Examination Survey (NHANES) 2007-2018 with reliable kidney stone and thyroid disease data were included. Adjusting for age, gender, race, education level, and marital status, diabetes, hypertension, gout, angina pectoris, stroke, and asthma, logistic regression was used to examine the relationship between kidney stones and thyroid illness.

Results: Using stratified analysis, the association between thyroid illness and kidney stones was investigated further. Among the participants, 4.9% had kidney stones, and 10.1% had thyroid disease. Kidney stone was associated with thyroid disease (OR=1.441, (95% CI:1.294-1.604), p <0.01), which remained significant (OR=1.166, (95% CI:1.041-1.305), p <0.01) after adjustments with age, gender, race, education level and marital status, diabetes, hypertension, gout, angina pectoris, stroke, and asthma. Stratified by blood lead, blood cadmium, and blood urea nitrogen levels in the human body, the odds of kidney stones still increased with once having a previous thyroid disease.

Conclusions: In this large nationally representative survey over 10 years, kidney stone was strongly associated with thyroid disease. In this cross-sectional study, we explored the association between thyroid disease and kidney stones, which may help clinicians intervene in them early.

« Previous Next »
Graphical Abstract

[1]
Khan, S.R.; Pearle, M.S.; Robertson, W.G.; Gambaro, G.; Canales, B.K.; Doizi, S.; Traxer, O.; Tiselius, H.G. Kidney stones. Nat. Rev. Dis. Primers, 2016, 2(1), 16008.
[http://dx.doi.org/10.1038/nrdp.2016.8] [PMID: 27188687]
[2]
Scales, C.D., Jr; Smith, A.C.; Hanley, J.M.; Saigal, C.S. Prevalence of kidney stones in the United States. Eur. Urol., 2012, 62(1), 160-165.
[http://dx.doi.org/10.1016/j.eururo.2012.03.052] [PMID: 22498635]
[3]
Corbo, J.; Wang, J. Kidney and ureteral stones. Emerg. Med. Clin. North Am., 2019, 37(4), 637-648.
[http://dx.doi.org/10.1016/j.emc.2019.07.004] [PMID: 31563199]
[4]
Srivastava, T.; Alon, U.S. Pathophysiology of hypercalciuria in children. Pediatr. Nephrol., 2007, 22(10), 1659-1673.
[http://dx.doi.org/10.1007/s00467-007-0482-6] [PMID: 17464515]
[5]
Press, D.M.; Siperstein, A.E.; Berber, E.; Shin, J.J.; Metzger, R.; Jin, J.; Monteiro, R.; Mino, J.; Swagel, W.; Mitchell, J.C. The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: A population-based analysis from the electronic medical record. Surgery, 2013, 154(6), 1232-1238.
[http://dx.doi.org/10.1016/j.surg.2013.06.051] [PMID: 24383100]
[6]
Walker, M.D.; Silverberg, S.J. Primary hyperparathyroidism. Nat. Rev. Endocrinol., 2018, 14(2), 115-125.
[http://dx.doi.org/10.1038/nrendo.2017.104] [PMID: 28885621]
[7]
Taylor, P.N.; Albrecht, D.; Scholz, A.; Gutierrez-Buey, G.; Lazarus, J.H.; Dayan, C.M.; Okosieme, O.E. Global epidemiology of hyperthyroidism and hypothyroidism. Nat. Rev. Endocrinol., 2018, 14(5), 301-316.
[http://dx.doi.org/10.1038/nrendo.2018.18] [PMID: 29569622]
[8]
Katz, A.I.; Emmanouel, D.S.; Lindheimer, M.D. Thyroid hormone and the kidney. Nephron, 1975, 15(3-5), 223-249.
[http://dx.doi.org/10.1159/000180514] [PMID: 1101087]
[9]
Iglesias, P.; Díez, J.J. Thyroid dysfunction and kidney disease. Eur. J. Endocrinol., 2009, 160(4), 503-515.
[http://dx.doi.org/10.1530/EJE-08-0837] [PMID: 19095779]
[10]
Iglesias, P.; Bajo, M.A.; Selgas, R.; Díez, J.J. Thyroid dysfunction and kidney disease: An update. Rev. Endocr. Metab. Disord., 2017, 18(1), 131-144.
[http://dx.doi.org/10.1007/s11154-016-9395-7] [PMID: 27864708]
[11]
Nackeeran, S.; Katz, J.; Ramasamy, R.; Marcovich, R. Association between sex hormones and kidney stones: Analysis of the national health and nutrition examination survey. World J. Urol., 2021, 39(4), 1269-1275.
[http://dx.doi.org/10.1007/s00345-020-03286-w] [PMID: 32504317]
[12]
Narasaki, Y.; Sohn, P.; Rhee, C.M. The interplay between thyroid dysfunction and kidney disease. Semin. Nephrol., 2021, 41(2), 133-143.
[http://dx.doi.org/10.1016/j.semnephrol.2021.03.008] [PMID: 34140092]
[13]
Suwazono, Y.; Sand, S.; Vahter, M.; Filipsson, A.F.; Skerfving, S.; Lidfeldt, J.; Åkesson, A. Benchmark dose for cadmium-induced renal effects in humans. Environ. Health Perspect., 2006, 114(7), 1072-1076.
[http://dx.doi.org/10.1289/ehp.9028] [PMID: 16835061]
[14]
Åkesson, A.; Lundh, T.; Vahter, M.; Bjellerup, P.; Lidfeldt, J.; Nerbrand, C.; Samsioe, G.; Strömberg, U.; Skerfving, S. Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ. Health Perspect., 2005, 113(11), 1627-1631.
[http://dx.doi.org/10.1289/ehp.8033] [PMID: 16263522]
[15]
Trzcinka-Ochocka, M.; Jakubowski, M.; Razniewska, G.; Halatek, T.; Gazewski, A. The effects of environmental cadmium exposure on kidney function: the possible influence of age. Environ. Res., 2004, 95(2), 143-150.
[http://dx.doi.org/10.1016/j.envres.2003.10.003] [PMID: 15147919]
[16]
Jin, T.; Nordberg, G.; Wu, X.; Ye, T.; Kong, Q.; Wang, Z.; Zhuang, F.; Cai, S. Urinary N-acetyl-beta-D-glucosaminidase isoenzymes as biomarker of renal dysfunction caused by cadmium in a general population. Environ. Res., 1999, 81(2), 167-173.
[http://dx.doi.org/10.1006/enrs.1999.3959] [PMID: 10433849]
[17]
Nawrot, T.S.; Staessen, J.A.; Roels, H.A.; Munters, E.; Cuypers, A.; Richart, T.; Ruttens, A.; Smeets, K.; Clijsters, H.; Vangronsveld, J. Cadmium exposure in the population: from health risks to strategies of prevention. Biometals, 2010, 23(5), 769-782.
[http://dx.doi.org/10.1007/s10534-010-9343-z] [PMID: 20517707]
[18]
Harita, N.; Hayashi, T.; Sato, K.K.; Nakamura, Y.; Yoneda, T.; Endo, G.; Kambe, H. Lower serum creatinine is a new risk factor of type 2 diabetes: The kansai healthcare study. Diabetes Care, 2009, 32(3), 424-426.
[http://dx.doi.org/10.2337/dc08-1265] [PMID: 19074997]
[19]
Waikar, S.S.; Curhan, G.C.; Wald, R.; McCarthy, E.P.; Chertow, G.M. Declining mortality in patients with acute renal failure, 1988 to 2002. J. Am. Soc. Nephrol., 2006, 17(4), 1143-1150.
[http://dx.doi.org/10.1681/ASN.2005091017] [PMID: 16495376]
[20]
Bushinsky, D.A.; Monk, R.D. Calcium. Lancet, 1998, 352(9124), 306-311.
[http://dx.doi.org/10.1016/S0140-6736(97)12331-5] [PMID: 9690425]
[21]
Cooper, D.S.; Biondi, B. Subclinical thyroid disease. Lancet, 2012, 379(9821), 1142-1154.
[http://dx.doi.org/10.1016/S0140-6736(11)60276-6] [PMID: 22273398]
[22]
Bahn, R.S.; Burch, H.B.; Cooper, D.S.; Garber, J.R.; Greenlee, M.C.; Klein, I.; Laurberg, P.; McDougall, I.R.; Montori, V.M.; Rivkees, S.A.; Ross, D.S.; Sosa, J.A.; Stan, M.N. Hyperthyroidism and other causes of thyrotoxicosis: Management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid, 2011, 21(6), 593-646.
[http://dx.doi.org/10.1089/thy.2010.0417] [PMID: 21510801]
[23]
Ross, D.S.; Burch, H.B.; Cooper, D.S.; Greenlee, M.C.; Laurberg, P.; Maia, A.L.; Rivkees, S.A.; Samuels, M.; Sosa, J.A.; Stan, M.N.; Walter, M.A. 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid, 2016, 26(10), 1343-1421.
[http://dx.doi.org/10.1089/thy.2016.0229] [PMID: 27521067]
[24]
Surks, M.I.; Ortiz, E.; Daniels, G.H.; Sawin, C.T.; Col, N.F.; Cobin, R.H.; Franklyn, J.A.; Hershman, J.M.; Burman, K.D.; Denke, M.A.; Gorman, C.; Cooper, R.S.; Weissman, N.J. Subclinical thyroid disease: Scientific review and guidelines for diagnosis and management. JAMA, 2004, 291(2), 228-238.
[http://dx.doi.org/10.1001/jama.291.2.228] [PMID: 14722150]
[25]
Garber, J.R.; Cobin, R.H.; Gharib, H.; Hennessey, J.V.; Klein, I.; Mechanick, J.I.; Pessah-Pollack, R.; Singer, P.A. Woeber for the American Association, K.A. Clinical practice guidelines for hypothyroidism in adults: Cosponsored by the american association of clinical endocrinologists and the american thyroid association. Thyroid, 2012, 22(12), 1200-1235.
[http://dx.doi.org/10.1089/thy.2012.0205] [PMID: 22954017]
[26]
Biondi, B.; Cappola, A.R.; Cooper, D.S. Subclinical hypothyroidism. JAMA, 2019, 322(2), 153-160.
[http://dx.doi.org/10.1001/jama.2019.9052] [PMID: 31287527]
[27]
Ross, D.S. Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease. Endocrinol. Metab. Clin. North Am., 2001, 30(2), 245-264.
[http://dx.doi.org/10.1016/S0889-8529(05)70186-9] [PMID: 11444162]
[28]
Sun, Y.; Zhou, Q.; Zheng, J. Nephrotoxic metals of cadmium, lead, mercury and arsenic and the odds of kidney stones in adults: An exposure-response analysis of NHANES 2007–2016. Environ. Int., 2019, 132, 105115.
[http://dx.doi.org/10.1016/j.envint.2019.105115] [PMID: 31473411]
[29]
Coe, F.L.; Worcester, E.M.; Evan, A.P. Idiopathic hypercalciuria and formation of calcium renal stones. Nat. Rev. Nephrol., 2016, 12(9), 519-533.
[http://dx.doi.org/10.1038/nrneph.2016.101] [PMID: 27452364]
[30]
Carbone, A.; Al Salhi, Y.; Tasca, A.; Palleschi, G.; Fuschi, A.; De Nunzio, C.; Bozzini, G.; Mazzaferro, S.; Pastore, A.L. Obesity and kidney stone disease: A systematic review. Minerva Urol. Nefrol., 2018, 70(4), 393-400.
[http://dx.doi.org/10.23736/S0393-2249.18.03113-2] [PMID: 29856171]
[31]
Nie, X.; Chen, Y.; Chen, Y.; Chen, C.; Han, B.; Li, Q.; Zhu, C.; Xia, F.; Zhai, H.; Wang, N.; Lu, Y. Lead and cadmium exposure, higher thyroid antibodies and thyroid dysfunction in Chinese women. Environ. Pollut., 2017, 230, 320-328.
[http://dx.doi.org/10.1016/j.envpol.2017.06.052] [PMID: 28667913]
[32]
Tribulova, N.; Knezl, V.; Shainberg, A.; Seki, S.; Soukup, T. Thyroid hormones and cardiac arrhythmias. Vascul. Pharmacol., 2010, 52(3-4), 102-112.
[http://dx.doi.org/10.1016/j.vph.2009.10.001] [PMID: 19850152]
[33]
Cherian, M.G.; Nordberg, M. Cellular adaptation in metal toxicology and metallothionein. Toxicology, 1983, 28(1-2), 1-15.
[http://dx.doi.org/10.1016/0300-483X(83)90101-4] [PMID: 6314607]
[34]
Thévenod, F. Nephrotoxicity and the proximal tubule. Insights from cadmium. Nephron, Physiol., 2003, 93(4), 87-p93.
[http://dx.doi.org/10.1159/000070241] [PMID: 12759569]
[35]
Nordberg, G.F.; Goyer, R.; Nordberg, M. Comparative toxicity of cadmium-metallothionein and cadmium chloride on mouse kidney. Arch. Pathol., 1975, 99(4), 192-197.
[PMID: 1115684]
[36]
Nordberg, G.F.; Nogawa, K.; Nordberg, M.; Friedmann, J.M. Cadmium. In: Handbook on the Toxicology of Metals; Nordberg, G.F.; Fowler, B.A.; Nordberg, M.; Friberg, L., Eds.; Elsevier: Amsterdam, The Netherlands, 2007; pp. 445-486.
[http://dx.doi.org/10.1016/B978-012369413-3/50078-1]
[37]
Buser, M.C.; Ingber, S.Z.; Raines, N.; Fowler, D.A.; Scinicariello, F. Urinary and blood cadmium and lead and kidney function: NHANES 2007–2012. Int. J. Hyg. Environ. Health, 2016, 219(3), 261-267.
[http://dx.doi.org/10.1016/j.ijheh.2016.01.005] [PMID: 26852280]
[38]
Madrigal, J.M.; Ricardo, A.C.; Persky, V.; Turyk, M. Associations between blood cadmium concentration and kidney function in the U.S. population: Impact of sex, diabetes and hypertension. Environ. Res., 2019, 169, 180-188.
[http://dx.doi.org/10.1016/j.envres.2018.11.009] [PMID: 30466011]
[39]
Nordberg, M.; Jin, T.; Nordberg, G.F. Cadmium, metallothionein and renal tubular toxicity. IARC Sci. Publ., 1992, 118(118), 293-297.
[PMID: 1303954]
[40]
Felley-Bosco, E.; Diezi, J. Fate of cadmium in rat renal tubules: A microinjection study. Toxicol. Appl. Pharmacol., 1987, 91(2), 204-211.
[http://dx.doi.org/10.1016/0041-008X(87)90101-3] [PMID: 3672521]
[41]
Courey, R.; Pfister, R.C. The radiographic findings in renal tubular acidosis: Analysis of 21 cases. Radiology, 1972, 105(3), 497-503.
[http://dx.doi.org/10.1148/105.3.497] [PMID: 4635084]
[42]
Singh, B.; Chandran, V.; Bandhu, H.K.; Mittal, B.R.; Bhattacharya, A.; Jindal, S.K.; Varma, S. Impact of lead exposure on pituitary-thyroid axis in humans. Biometals, 2000, 13(2), 187-192.
[http://dx.doi.org/10.1023/A:1009201426184] [PMID: 11016408]
[43]
Harari, F.; Sallsten, G.; Christensson, A.; Petkovic, M.; Hedblad, B.; Forsgard, N.; Melander, O.; Nilsson, P.M.; Borné, Y.; Engström, G.; Barregard, L. Blood lead levels and decreased kidney function in a population-based cohort. Am. J. Kidney Dis., 2018, 72(3), 381-389.
[http://dx.doi.org/10.1053/j.ajkd.2018.02.358] [PMID: 29699886]
[44]
Frassetto, L.; Kohlstadt, I. Treatment and prevention of kidney stones: An update. Am. Fam. Physician, 2011, 84(11), 1234-1242.
[PMID: 22150656]
[45]
Murphy, E.; Williams, G.R. The thyroid and the skeleton. Clin. Endocrinol., 2004, 61(3), 285-298.
[http://dx.doi.org/10.1111/j.1365-2265.2004.02053.x] [PMID: 15355444]
[46]
Barboza, G.D.; Guizzardi, S.; Talamoni, N.T. Molecular aspects of intestinal calcium absorption. World J. Gastroenterol., 2015, 21(23), 7142-7154.
[http://dx.doi.org/10.3748/wjg.v21.i23.7142] [PMID: 26109800]
[47]
Çetin, M.; Erdoğan, T.; Özyıldız, A.G.; Özer, S.; Ayhan, A.Ç.; Kırış, T. Blood urea nitrogen is associated with long-term all-cause mortality in stable angina pectoris patients: 8-year follow-up results. Kardiologiia, 2021, 61(3), 66-70.
[http://dx.doi.org/10.18087/cardio.2021.3.n1368] [PMID: 33849421]
[48]
Ardawi, M.S.M.; Jalalah, S.M. Effects of hypothyroidism on glucose and glutamine metabolism by the gut of the rat. Clin. Sci., 1991, 81(3), 347-355.
[http://dx.doi.org/10.1042/cs0810347] [PMID: 1655336]
[49]
Kulkarni, V.; Ramteke, H.; Lamture, Y.; Gharde, P. A review of synchronous findings of hypothyroidism and cholelithiasis. Cureus, 2022, 14(10), e30316.
[http://dx.doi.org/10.7759/cureus.30316] [PMID: 36381858]
[50]
Al-Jubouri, M.A.; Briston, P.G.; Sinclair, D.; Chinn, R.H.; Young, R.M. Lesson of the Week: Myxoedema revealed by simvastatin induced myopathy. BMJ, 1994, 308(6928), 588.
[http://dx.doi.org/10.1136/bmj.308.6928.588] [PMID: 8148686]
[51]
Ahmad, S. Lovastatin-induced myopathy in a hypothyroid patient. J. Fam. Pract., 1995, 41(3), 227-228.
[PMID: 7650497]
[52]
Hung, Y.T.; Yeung, V.T. Hypothyroidism presenting as hypercholesterolaemia and simvastatin-induced myositis. Hong Kong Med. J., 2000, 6(4), 423-424.
[PMID: 11177166]
[53]
Gemici, G.; Toprak, A.; Oktay, A. Rhabdomyolysis due to cerivastatin monotherapy. Am. J. Med., 2001, 110(9), 742.
[http://dx.doi.org/10.1016/S0002-9343(01)00730-6] [PMID: 11417566]
[54]
Rando, L.P.; Cording, S.A.L.; Newnham, H.H. Successful reintroduction of statin therapy after myositis: Was there another cause? Med. J. Aust., 2004, 180(9), 472-473.
[http://dx.doi.org/10.5694/j.1326-5377.2004.tb06030.x] [PMID: 15115429]
[55]
Tokinaga, K.; Oeda, T.; Suzuki, Y.; Matsushima, Y. HMG-CoA reductase inhibitors (statins) might cause high elevations of creatine phosphokinase (CK) in patients with unnoticed hypothyroidism. Endocr. J., 2006, 53(3), 401-405.
[http://dx.doi.org/10.1507/endocrj.K04-144] [PMID: 16723812]
[56]
Bar, S.L.; Holmes, D.T.; Frohlich, J. Asymptomatic hypothyroidism and statin-induced myopathy. Can. Fam. Physician, 2007, 53(3), 428-431.
[PMID: 17872677]
[57]
Hilton-Jones, D. Myopathy associated with statin therapy. Neuromuscul. Disord., 2008, 18(1), 97-98.
[http://dx.doi.org/10.1016/j.nmd.2007.08.008] [PMID: 17892936]
[58]
Krieger, E.V.; Knopp, R.H. Hypothyroidism misdiagnosed as statin intolerance. Ann. Intern. Med., 2009, 151(1), 72.
[http://dx.doi.org/10.7326/0003-4819-151-1-200907070-00018] [PMID: 19581652]
[59]
Qari, F.A. Severe rhabdomyolysis and acute renal failure secondary to use of simvastatin in undiagnosed hypothyroidism. Saudi J. Kidney Dis. Transpl., 2009, 20(1), 127-129.
[PMID: 19112232]
[60]
Ambapkar, S.N.; Shetty, N.; Dwivedy, A.; Malve, H.O. Statin-induced rhabdomyolysis in patient with renal failure and underlying undiagnosed hypothyroidism. Indian J. Crit. Care Med., 2016, 20(5), 305-307.
[http://dx.doi.org/10.4103/0972-5229.182210] [PMID: 27275082]
[61]
Ahn, P.; Min, H.J.; Park, S.H.; Lee, B.M.; Choi, M.J.; Yoon, J.W.; Koo, J.R. Rhabdomyolysis and acute kidney injury associated with hypothyroidism and statin therapy. Endocrinol. Metab., 2013, 28(4), 331-334.
[http://dx.doi.org/10.3803/EnM.2013.28.4.331] [PMID: 24396699]
[62]
Ram, R.; Swarnalatha, G.; Ramesh, V.; Rao, K.N.; Dakshinamurty, K.V. Rhabdomyolysis induced acute renal failure secondary to statins. Indian J. Nephrol., 2013, 23(3), 211-213.
[http://dx.doi.org/10.4103/0971-4065.111853] [PMID: 23814421]
[63]
Peringat, J.; Manappallil, R.G.; Karadan, U. Rhabdomyolysis: A rare complication of Hashimoto’s thyroiditis precipitated by statin therapy. BMJ Case Rep., 2018, 2018, bcr-2017-223229.
[http://dx.doi.org/10.1136/bcr-2017-223229] [PMID: 29440138]
[64]
Chiang, W.F.; Chan, J.S.; Hsiao, P.J.; Lin, S.H. Case report: Rhabdomyolysis and kidney injury in a statin-treated hypothyroid patient-kill two birds with one stone. Front. Med., 2022, 9, 1046330.
[http://dx.doi.org/10.3389/fmed.2022.1046330] [PMID: 36438056]
[65]
Klein, I.; Ojamaa, K. Thyroid hormone and the cardiovascular system. N. Engl. J. Med., 2001, 344(7), 501-509.
[http://dx.doi.org/10.1056/NEJM200102153440707] [PMID: 11172193]
[66]
Dillmann, W.H. Cellular action of thyroid hormone on the heart. Thyroid, 2002, 12(6), 447-452.
[http://dx.doi.org/10.1089/105072502760143809] [PMID: 12165105]
[67]
Jabbar, A.; Pingitore, A.; Pearce, S.H.S.; Zaman, A.; Iervasi, G.; Razvi, S. Thyroid hormones and cardiovascular disease. Nat. Rev. Cardiol., 2017, 14(1), 39-55.
[http://dx.doi.org/10.1038/nrcardio.2016.174] [PMID: 27811932]
[68]
Marín-García, J. Thyroid hormone and myocardial mitochondrial biogenesis. Vascul. Pharmacol., 2010, 52(3-4), 120-130.
[http://dx.doi.org/10.1016/j.vph.2009.10.008] [PMID: 19857604]
[69]
Dratman, M.B.; Gordon, J.T. Thyroid hormones as neurotransmitters. Thyroid, 1996, 6(6), 639-647.
[http://dx.doi.org/10.1089/thy.1996.6.639] [PMID: 9001201]
[70]
Andersson, KE The overactive bladder: Pharmacologic basis of drug treatment. Urology, 1997, 50(6A Suppl), 74-84.
[http://dx.doi.org/10.1016/S0090-4295(97)00595-5]
[71]
Prezioso, G.; Giannini, C.; Chiarelli, F. Effect of thyroid hormones on neurons and neurodevelopment. Horm. Res. Paediatr., 2018, 90(2), 73-81.
[http://dx.doi.org/10.1159/000492129] [PMID: 30157487]
[72]
Jones, P.; Karim Sulaiman, S.; Gamage, K.N.; Tokas, T.; Jamnadass, E.; Somani, B.K. Do lifestyle factors including smoking, alcohol, and exercise impact your risk of developing kidney stone disease? outcomes of a systematic review. J. Endourol., 2021, 35(1), 1-7.
[http://dx.doi.org/10.1089/end.2020.0378] [PMID: 32808537]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy